T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study

PURPOSE: Genetically engineered T-cell therapy is an emerging treatment of hematologic cancers with potential utility in epithelial cancers. We investigated T-cell therapy for the treatment of metastatic human papillomavirus (HPV)–associated epithelial cancers. METHODS: This phase I/II, single-cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Doran, Stacey L., Stevanović, Sanja, Adhikary, Sabina, Gartner, Jared J., Jia, Li, Kwong, Mei Li M., Faquin, William C., Hewitt, Stephen M., Sherry, Richard M., Yang, James C., Rosenberg, Steven A., Hinrichs, Christian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800280/
https://www.ncbi.nlm.nih.gov/pubmed/31408414
http://dx.doi.org/10.1200/JCO.18.02424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800280/
https://www.ncbi.nlm.nih.gov/pubmed/31408414
http://dx.doi.org/10.1200/JCO.18.02424

Ejemplares similares